COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,009 Articles (22,627 medRxiv, 8,382 bioRxiv)

Most recent first Previous |  Page 1139: Articles 11381-11390  | Next

Nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants
Maeda, R., Fujita, J., Konishi, Y., Kazuma, Y., Yamazaki, H., Anzai, I., Yamaguchi, K., Kasai, K., Nagata, K., Yamaoka, Y., Miyakawa, K., Ryo, A., Shirakawa, K., Makino, F., Matsuura, Y., Inoue, T., Imura, A., Namba, K., Takaori-Kondo, A.
10.1101/2021.10.25.465714 — Posted: 2021-10-26
Structure, receptor recognition and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein
Tortorici, M. A., Walls, A. C., Joshi, A., Park, Y.-J., Eguia, R. T., Stevens-Ayers, T., Boeckh, M. J., Talenti, A., Lanzavecchia, A., Corti, D., Bloom, J. D., Veesler, D.
10.1101/2021.10.25.465646 — Posted: 2021-10-26
Targeting the chemokine receptor CXCR4 with histamine analogue to reduce inflammation in juvenile arthritis: a proof of concept for COVID-19 therapeutic approach
Bekaddour, N., Smith, N., Beitz, B., Llibre, A., Dott, T., Baudry, A., Korganow, A.-S., Nisole, S., Mouy, R., Breton, S., Bader-Meunier, B., Duffy, D., Terrier, B., Schneider, B., Quartier, P., Rodero, M., Herbeuval, J.-P.
10.1101/2021.10.24.465080 — Posted: 2021-10-26
COVID 19 breakthrough infection risk: a simple physical model describing the dependence on antibody concentration
Williams, D.
10.1101/2021.10.25.465798 — Posted: 2021-10-26
Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection
Tyner, H. L., Thompson, M. G., Burgess, J. L., Grant, L., Gaglani, M., Kuntz, J. L., Naleway, A. L., Thornburg, N. J., Caban-Martinez, A. J., Yoon, S. K., Herring, M. K., Beitel, S. C., Blanton, L., Nikolich-Zugich, J., Thiese, M. S., Flores Pleasants, J., Fowlkes, A. L., Lutrick, K., Dunnigan, K., Yoo, Y. M., Rose, S., Groom, H., Meece, J., Wesley, M. G., Schaefer-Solle, N., Louzado-Feliciano, P., Edwards, L. J., Olsho, L. E. W.
10.1101/2021.10.20.21265171 — Posted: 2021-10-26
COVID-19 Observations from Hospitalized Ward Patients in the Northern Emirates: A Practice Only Preached.
Qureshi, S., Kampani, D. D., Al-Qutbi, T. A. H.
10.1101/2021.10.20.21265254 — Posted: 2021-10-26
Mathematical modeling of COVID-19 in British Columbia:an age-structured model with time-dependent contact rates
Iyaniwura, S. A., Falcão, R. C., Ringa, N., Adu, P., Spencer, M., Taylor, M., Colijn, C., Coombs, D., Janjua, N. Z., Irvine, M., Otterstatter, M.
10.1101/2021.10.19.21265177 — Posted: 2021-10-26
Preclinical and clinical validation of a novel injected molded swab for molecular assay detection of SARS-CoV-2 virus
Ghezzi, C. E., Hartigan, D. R., Hardick, J., Gore, R., Adelfio, M., Diaz, A. R., McGuiness, P. D., Robinson, M. L., Buchholz, B. O., Manabe, Y. C. L.
10.1101/2021.10.19.21265200 — Posted: 2021-10-26
The Relationship Between Food Security and Dietary Patterns Status with COVID-19 in Northeastern Iran: Protocol for a Case-Control Study
Badri-Fariman, S., Pourghassem-Gargari, B., Badri-Fariman, M., Pourfridoni, M., Daneshi-Maskooni, M.
10.1101/2021.10.20.21265103 — Posted: 2021-10-26
Early COVID-related Acute Kidney Injury Recovery May Course with Hydroelectrolytic Disorders in Patients With High Risk of Insensible Fluid Loss
Braga Barbosa, G. S., de Jesus Torres de Melo, A. G., Gomes Ribeiro, R., del Pilar Via Reque Cortes, D., Sandoval Cabrera, C. P., Santos Andrade Filho, R., Tamborra Pantaroto, G., de Castro Paul Schultze, B., Paula, G. A., Rodrigues, C. E.
10.1101/2021.10.20.21265300 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).